Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
Atomo Diagnostics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.71 | 3.22 | 3.69 | 6.47 | 12.97 |
Cash & Short-Term Investments | 3.71 | 3.22 | 3.69 | 6.47 | 12.97 |
Cash Growth | 15.19% | -12.70% | -43.00% | -50.10% | -27.75% |
Accounts Receivable | 1.83 | 0.62 | 1.23 | 0.68 | 0.92 |
Other Receivables | 1.39 | 1.08 | 0.83 | 1.14 | 1.76 |
Receivables | 3.22 | 1.69 | 2.06 | 1.82 | 2.68 |
Inventory | 1.97 | 1.65 | 1.84 | 2.14 | 3.42 |
Total Current Assets | 8.9 | 6.56 | 7.59 | 10.43 | 19.07 |
Property, Plant & Equipment | 0.7 | 1.07 | 1.72 | 2.74 | 3.98 |
Other Intangible Assets | 0.86 | 1.03 | 1.19 | 1.36 | 1.37 |
Long-Term Deferred Charges | 0.36 | 0.62 | 0.88 | 1.94 | 2.2 |
Total Assets | 10.83 | 9.28 | 11.38 | 16.47 | 26.62 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.05 | 0.38 | 0.48 | 0.18 | 0.38 |
Accrued Expenses | 0.5 | 0.44 | 0.5 | 0.89 | 0.92 |
Current Portion of Leases | 0.26 | 0.16 | 0.08 | 0.17 | 0.16 |
Current Unearned Revenue | 1.06 | 1.12 | 0.05 | 0.19 | - |
Other Current Liabilities | 0.06 | 0.06 | 0.08 | 0.07 | 0.08 |
Total Current Liabilities | 2.93 | 2.17 | 1.19 | 1.49 | 1.53 |
Long-Term Leases | 0.12 | 0.03 | - | 0.08 | 0.18 |
Other Long-Term Liabilities | 0.07 | 0.11 | 0.11 | 0.1 | 0.09 |
Total Liabilities | 3.12 | 2.3 | 1.29 | 1.68 | 1.81 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 75.83 | 71.84 | 70.09 | 68.04 | 68.04 |
Retained Earnings | -68.47 | -64.95 | -60.09 | -53.55 | -44.03 |
Comprehensive Income & Other | 0.35 | 0.09 | 0.09 | 0.3 | 0.8 |
Shareholders' Equity | 7.71 | 6.98 | 10.08 | 14.79 | 24.81 |
Total Liabilities & Equity | 10.83 | 9.28 | 11.38 | 16.47 | 26.62 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.37 | 0.19 | 0.08 | 0.25 | 0.34 |
Net Cash (Debt) | 3.34 | 3.03 | 3.6 | 6.22 | 12.63 |
Net Cash Growth | 9.93% | -15.78% | -42.03% | -50.77% | -29.38% |
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
Filing Date Shares Outstanding | 902.43 | 810.18 | 639.2 | 570.89 | 570.89 |
Total Common Shares Outstanding | 902.43 | 739.12 | 639.2 | 570.89 | 570.89 |
Working Capital | 5.97 | 4.4 | 6.4 | 8.94 | 17.53 |
Book Value Per Share | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 |
Tangible Book Value | 6.84 | 5.95 | 8.89 | 13.43 | 23.44 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
Machinery | 7.21 | 7.17 | 7.14 | 7.13 | 7.07 |
Leasehold Improvements | 0.49 | 0.48 | 0.47 | 0.47 | 0.46 |